Match Document Document Title
US20120004119 GENE EXPRESSION MARKERS OF ONCOLYTIC VIRUS SENSITIVITY  
A method of predicting an efficacy of an oncolytic virus treatment for a tumor comprises calculating a single-gene predictor score for each of a plurality of genes; calculating a predictor score...
US20150011410 METHODS AND KITS FOR DETECTING SUBJECTS AT RISK OF HAVING CANCER  
The present invention relates to agents and methods for screening, diagnosis and surveillance of cancer, in particular pancreatic cancer.
US20130095099 GENES AND GENES COMBINATIONS PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM INFLAMMATORY DISEASE TO CYTOKINE TARGETING DRUGS (CYTD)  
The invention concerns methods for the in vitro diagnosis/prognosis of a CyTD responsive or non-responsive phenotype, comprising: (a) determining from a subject biological sample an expression...
US20150087539 METHOD FOR PREDICTING OUTCOME OF CANCER IN A SUBJECT  
The invention relates to a method for predicting the outcome of a subject suffering from cancer, based on the copy number of the CHKA gene in a sample from said subject. The invention also relates...
US20130065782 Renal Cell Carcinoma Biomarkers and Uses Thereof  
The subject disclosure concerns methods for evaluation of renal cell carcinoma (RCC). Such methods include a method of determining of a diagnosis of the individual as having or not having RCC;...
US20140235479 SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF  
The present invention provides methods of detecting cancer using biomarkers.
US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof  
The present invention provides methods of detecting cancer using biomarkers.
US20130045874 Method of Diagnostic of Inflammatory Bowel Diseases  
A new method for diagnosing an inflammatory bowel disease is herein described, based on the determination of the absence of at least one gene from the human' gut microbiome.
US20150051100 DNA HYPERMETHYLATION OF PROMOTERS OF TARGET GENES AND CLINICAL DIAGNOSIS AND TREATMENT OF HPV RELATED DISEASE  
The present invention provides arrays for gene loci that allow diagnosis of cervical cancer in patients who may be asymptomatic or have inconclusive Pap smears or cytology, and allowing earlier...
US20140303024 MARKERS OF ACUTE KIDNEY FAILURE  
The present invention relates to a method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any...
US20130172205 MARKERS OF ACUTE KIDNEY FAILURE  
The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any...
US20110177967 METHODS AND COMPOSITIONS USING SPLICING REGULATORY PROTEINS INVOLVED IN TUMOR SUPPRESSION  
Methods and compositions for diagnosis and prognosis of mammalian carcinoma or cancer derived from primary epithelial cells and tissue fibrosis are designed using newly identified epithelial...
US20120252694 MARKERS, METHODS, BIOCHIPS AND KITS FOR MILK QUALITY DETECTION  
This invention provides markers, methods, biochips and kits for milk quality detection. The present invention particularly provides a method for milk quality detection by means of detecting the...
US20120283142 siRNA Targeting Amyloid Beta (A4) Precursor Protein (APP)  
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene...
US20110021382 siRNA targeting amyloid beta (A4) precursor protein (APP)  
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene...
US20140045702 SYSTEMS AND METHODS FOR DISTINGUISHING BETWEEN AUTISM SPECTRUM DISORDERS (ASD) AND NON-ASD DEVELOPMENT DELAY  
Methods and systems are presented herein to distinguish children with Autism Spectrum Disorders (ASD) from those with other forms of developmental delay (DD) based on patterns of gene expression...
US20150023984 Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment  
Compositions and methods for the detection and treatment of T1D are provided.
US20110243922 Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment  
Compositions and methods for the detection and treatment of T1D are provided.
US20150031578 DEVICES AND METHODS FOR PROGNOSIS PREDICTION FOR MELANOMA CANCER  
The invention relates to prognostic markers and prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for melanoma. Specifically,...
US20100304985 METHODS AND COMPOSITIONS FOR DETERMINING WHETHER A SUBJECT CARRIES A DISEASE ASSOCIATED GENE MUTATION COMMON IN JEWISH POPULATIONS  
Methods are provided for determining whether a subject carries a disease associated gene mutation common in Jewish populations. In practicing the subject methods, an array comprising a plurality...
US20140302056 DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER  
Disclosed herein are methods and compositions useful for the diagnosis and treatment of angiogenic disorders, including, e.g., cancer.
US20140099326 DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER  
Disclosed herein are methods and compositions useful for the diagnosis and treatment of angiogenic disorders, including, e.g., cancer.
US20130059747 MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER  
The present invention provides methods for providing a prognosis for lung cancer using a panel of eleven molecular markers that includes BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3,...
US20130338012 GENETIC RISK FACTORS OF SICK SINUS SYNDROME  
It has been found that certain alleles of the human MYH6 gene are predictive of risk of certain conditions, including Sick Sinus Syndrome, Atrial Fibrillation, Pacemaker implantation and Thoracic...
US20150259740 PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER  
Life-threatening traumas such as terrorist attacks, war, disasters, mental or physical assault, severe accidents and violence frequently provoke emotional and behavioral disturbances known as...
US20120220467 Genetic Determinants of Prostate Cancer Risk  
Described are methods of determining if a subject has a genetic predisposition to developing prostate cancer (PCa).
US20140315935 GENE SIGNATURES FOR LUNG CANCER PROGNOSIS AND THERAPY SELECTION  
The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.
US20140170242 GENE SIGNATURES FOR LUNG CANCER PROGNOSIS AND THERAPY SELECTION  
The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.
US20130023445 DIMERIC DIAGNOSTIC ARRAYS  
The invention provides dimeric diagnostic arrays and methods for their use.
US20150105276 BLOOD-BASED GENE DETECTION OF NON-SMALL CELL LUNG CANCER  
The present invention provides a method for early detection of non-small cell lung cancer based on the abundance of RNAs from blood samples as well as diagnostic tools such as kits and arrays...
US20120020954 METHODS OF PREDICTING CLINICAL COURSE AND TREATING MULTIPLE SCLEROSIS  
Provided are methods and kits for classifying a subject as being more likely to have benign multiple sclerosis (BMS) or as being more likely to have typical relapsing remitting multiple sclerosis...
US20120004113 DNA CHIP, KIT FOR DETECTING OR GENOTYPING BACTERIA CAUSING SEXUALLY TRANSMITTED DISEASES, GENOTYPING ANTIBACTERIAL DRUG RESISTANCE AND DETECTING OR GENOTYPING METHOD USING THE SAME  
Disclosed are a DNA chip and a kit capable of quickly and accurately detecting or genotyping the highly prevalent and important eleven microbes causing sexually transmitted diseases (STD)...
US20140314786 HUMAN INVASION SIGNATURE FOR PROGNOSIS OF METASTATIC RISK  
Methods and products are provided for determining if a subject having a tumor is (i) at risk of metastasis of the tumor, or (ii) at risk of recurrence of the tumor after treatment of the tumor....
US20110028347 SUPPORT CARRYING AN IMMOBILIZED SELECTIVE BINDING SUBSTANCE  
A support carrying an immobilized selective binding substance, that the support surface has a polymer containing the structural unit represented by the following General Formula (1) in an amount...
US20110015097 SUPPORT CARRYING AN IMMOBILIZED SELECTIVE BINDING SUBSTANCE  
A support carrying an immobilized selective binding substance, that the support surface has a polymer containing the structural unit represented by the following General Formula (1) in an amount...
US20110319296 siRNA targeting histamine receptor H1  
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene...
US20110034345 METHODS FOR DIAGNOSIS OF MACULOPATHIES  
The present disclosure provides methods for diagnosing a maculopathy. Specifically, the methods are based on determination of a level of at least one biological marker of a maculopathy in a bodily...
US20120135033 MULTIPLE DELIVERY SYSTEM FOR HETEROLOGOUS ANTIGENS  
The invention is directed to an episomal recombinant nucleic acid encoding at least two heterologous antigens each fused to a PEST-endogenous polypeptide, vaccines comprising the same, methods of...
US20140349856 Neuroendocrine Tumors  
The disclosure provides methods for the use of gene expression measurements to classify or identify neuroendocrine cancer in samples obtained from a subject in a clinical setting, such as in cases...
US20140187430 Compositions and Methods for Identifying Autism Spectrum Disorders  
The invention provides methods of identifying DNA methylation profiles for neurological and psychiatric conditions including autism spectrum disorders, methods of treating such conditions, and...
US20150184248 METHOD FOR DETECTING PANCREATIC CANCER AND DETECTION KIT  
An object of the invention is to provide a simple and easy method for detecting pancreatic cancer having high sensitivity and specificity or risk of the pancreatic cancer. The present invention...
US20100297152 METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF SCREENING FOR MODULATORS OF PROSTATE CANCER  
Described herein are genes whose expression are up-regulated or down-regulated in prostate cancer. Also described are such genes whose expression is further up-regulated or down-regulated in...
US20140073686 COMPOSITIONS FOR MODULATING INVASION ABILITY OF A TUMOR AND METHODS THEREOF  
The present invention provides a composition for modulating invasion ability of a tumor, comprising: an effective amount of an activator for a miRNA-mediated pathway or an effective amount of a...
US20110319297 siRNA targeting gremlin  
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene...
US20120065892 SCORING SYSTEM FOR THE PREDICTION OF CANCER RECURRENCE  
The present invention relates to a scoring system for the prediction of cancer recurrence by selecting genes and/or proteins whose expression patterns associated with recurrence of cancer, and...
US20120258183 MACRONUTRIENT SENSITIVITY  
The present invention relates to a method and a kit for identifying a subjects macronutrient sensitivity. The method involves assaying a genetic sample from the subject to determine a polymorphism...
US20120094859 METHODS FOR DETECTION OF DEPRESSIVE DISORDERS  
The present invention relates generally to the detection or diagnosis of depressive disorders, and provides methods and compositions useful for this purpose. In particular, the present invention...
US20140309131 METHOD FOR SCREENING INDUCED PLURIPOTENT STEM CELLS  
The present invention provides a method for screening for iPS cells exhibiting differentiation resistance using a marker identified as lincRNA or mRNA that is specifically expressed in an iPS cell...
US20150111758 GENE SIGNATURES ASSOCIATED WITH EFFICACY OF POSTMASTECTOMY RADIOTHERAPY IN BREAST CANCER  
The present invention relates to compositions, kits, and methods for providing a prognosis and/or determining a treatment course of action in a subject diagnosed with breast cancer. In particular,...
US20150232940 METHODS AND COMPOSITIONS RELATING TO DIAGNOSING AND TREATING RECEPTOR TYROSINE KINASE RELATED CANCERS  
Disclosed are methods and compositions for detecting the presence of a cancer in a subject and assessing the efficacy of treatments for the same. The disclosed method use reverse transcription...